{"date":"2026-03-24","count":25,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6589-2026-03-24-2119-1r5xwvq","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-24","time":"21:19:02","subject":"本公司及銷售夥伴Sandoz就EG1206Apertuzumab生物相似藥於美國及歐洲市場，與Genentech及Roche達成協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-24 21:19，「本公司及銷售夥伴Sandoz就EG1206Apertuzumab生物相似藥於美國及歐洲市場，與Genentech及Roc」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-03-24-2003-11wjw0o","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"20:03:38","subject":"公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-03-24 20:03，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-03-24-1924-11b1948","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"19:24:35","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-03-24 19:24，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-03-24-1847-1kg82et","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"18:47:36","subject":"本公司將於115年03月25日召開線上法人說明會","clause":"第12款","fact_date":"2026-03-25","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-03-24 18:47，「本公司將於115年03月25日召開線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-03-24-1815-of4zj3","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"18:15:46","subject":"公告本公司董事會決議盈餘轉增資發行新股案","clause":"第9款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-03-24 18:15，「公告本公司董事會決議盈餘轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-03-24-1803-11b1948","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"18:03:53","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-03-24 18:03，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-03-24-1756-2iz4hx","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:56:20","subject":"公告本公司董事會決議不發放股利","clause":"第31款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-03-24 17:56，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-03-24-1736-1nb8hvk","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:36:44","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-03-24 17:36，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-03-24-1730-1nb8hvk","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:30:13","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-03-24 17:30，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-03-24-1726-ks7cv2","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:26:06","subject":"公告董事會決議召開115年股東常會事宜","clause":"第32款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-03-24 17:26，「公告董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-03-24-1724-ra2cz7","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:24:18","subject":"公告本公司董事會通過114年度董事及員工酬勞分配案","clause":"第44款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-03-24 17:24，「公告本公司董事會通過114年度董事及員工酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-03-24-1722-16xqolo","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:22:54","subject":"更新公告本公司3/12董事會決議通過對100％投資之子公司越南台灣普惠醫療工藝責任有限公司現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-03-24 17:22，「更新公告本公司3/12董事會決議通過對100％投資之子公司越南台灣普惠醫療工藝責任有限公司現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-03-24-1718-5j9yh6","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:18:54","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-03-24 17:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-03-24-1703-bwopfv","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"17:03:55","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-03-24 17:03，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-03-24-1646-iiunc5","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"16:46:58","subject":"公告本公司115年03月24日董事會重要決議事項","clause":"第44款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-03-24 16:46，「公告本公司115年03月24日董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-03-24-1556-fu85v6","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"15:56:04","subject":"本公司董事會決議召開115年股東常會事宜(更正議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-03-24 15:56，「本公司董事會決議召開115年股東常會事宜(更正議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-24-1554-1t2gork","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-24","time":"15:54:43","subject":"代重要子公司永信藥品工業股份有限公司公告董事會決議股利分配","clause":"第14款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-24 15:54，「代重要子公司永信藥品工業股份有限公司公告董事會決議股利分配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-03-24-1554-14bnm4x","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-03-24","time":"15:54:29","subject":"代重要子公司永信藥品工業股份有限公司公告董事會重要決議事項","clause":"第51款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-03-24 15:54，「代重要子公司永信藥品工業股份有限公司公告董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-03-24-1535-1lv9a3w","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"15:35:59","subject":"本公司授權信達生物製藥（蘇州）有限公司IBI302關鍵三期註冊臨床試驗(STAR研究)達成主要終點","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-03-24 15:35，「本公司授權信達生物製藥（蘇州）有限公司IBI302關鍵三期註冊臨床試驗(STAR研究)達成主要終點」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-03-24-1511-ps7z81","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"15:11:34","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"第6款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-24 15:11，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-03-24-1511-qrsqda","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-24","time":"15:11:05","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-24 15:11，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-24-1509-wshfu9","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"15:09:23","subject":"代重要子公司潤雅生技股份有限公司公告董事會決議114年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-24 15:09，「代重要子公司潤雅生技股份有限公司公告董事會決議114年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-24-1508-1gz39l3","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"15:08:18","subject":"代重要子公司潤雅生技股份有限公司公告董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-24 15:08，「代重要子公司潤雅生技股份有限公司公告董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-03-24-1436-1bp30o","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"14:36:32","subject":"公告本公司董事會決議召開115年股東常會相關事宜(變更召開地點)","clause":"第17款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-03-24 14:36，「公告本公司董事會決議召開115年股東常會相關事宜(變更召開地點)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-24-1136-v3eu7k","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-24","time":"11:36:59","subject":"公告本公司董事長訂定民國114年第4季盈餘之除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-24 11:36，「公告本公司董事長訂定民國114年第4季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}